Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-58.98	21.03	51.27
Graham Fair Price	25.21	8400.39	6709.00
PEG	-49.89	-0.02	0.05
Price/Book	2.46	0.91	0.88
Price/Cash Flow	274.66	35.47	9.47
Prices/Earnings	-32.69	6.15	-9.14
Price/Sales	-12.10	1.44	1.63
Price/FCF	274.66	35.47	9.47
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.32	0.23	0.21
Operating Margin	462.54	0.08	0.01
ROA	49.85	0.01	< 0.005
ROE	-0.02	0.04	52.22
ROIC	< 0.005	0.02	193.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.08	-0.15	-49.61
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.84	5.63	566.64
EPS QOQ	-1.89	2.54	34.33
FCF QOQ	2.44	-0.72	-70.34
Revenue QOQ	-0.09	0.18	103.62
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	164.65	140.87	-14.44
Days Sales Outstanding (DSO)	97.27	86.35	-11.23
Inventory Turnover	0.55	0.64	16.88
Debt/Capitalization	0.41	0.43	3.76
Quick Ratio	0.75	0.79	5.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9096.73	9231.99	1.49
Cash	1426.18	2018.37	41.52
Capex	-190.68	-302.17	-58.47
Free Cash Flow	849.16	235.67	-72.25
Revenue	4919.26	5819.28	18.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.57	1.55	-1.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.49	8.35	-59.25
Naive Interpretation	Member

06 - Financial Health · Weak

Rating